Mill Creek Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74M | Sell |
9,217
-325
| -3% | -$132K | 0.08% | 69 |
|
|
2025
Q1 | $4.75M | Buy |
9,542
+1,202
| +14% | +$598K | 0.12% | 55 |
|
|
2024
Q4 | $4.34M | Sell |
8,340
-827
| -9% | -$430K | 0.1% | 59 |
|
|
2024
Q3 | $5.67M | Sell |
9,167
-4,149
| -31% | -$2.57M | 0.14% | 47 |
|
|
2024
Q2 | $7.36M | Buy |
13,316
+19
| +0.1% | +$10.5K | 0.19% | 42 |
|
|
2024
Q1 | $7.73M | Sell |
13,297
-3,497
| -21% | -$2.03M | 0.21% | 40 |
|
|
2023
Q4 | $8.91M | Buy |
16,794
+7,047
| +72% | +$3.74M | 0.26% | 34 |
|
|
2023
Q3 | $4.93M | Sell |
9,747
-114
| -1% | -$57.7K | 0.16% | 43 |
|
|
2023
Q2 | $5.15M | Buy |
9,861
+702
| +8% | +$366K | 0.17% | 43 |
|
|
2023
Q1 | $5.28M | Sell |
9,159
-11
| -0.1% | -$6.34K | 0.19% | 38 |
|
|
2022
Q4 | $5.05M | Buy |
+9,170
| New | +$5.05M | 0.21% | 36 |
|